Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma
- PMID: 17141972
- PMCID: PMC4125020
- DOI: 10.1016/j.ijrobp.2006.08.078
Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma
Abstract
Background: The purpose of this study was to assess the ability of intensity-modulated radiation therapy (IMRT) to achieve favorable disease-control rates while minimizing parotid gland doses in patients treated for small primary tumors of the oropharynx.
Methods and materials: We retrospectively identified all patients who received IMRT as treatment for a small (<4 cm) primary tumor of the oropharynx between October 2000 and June 2002. Tumor characteristics, IMRT parameters, and patient outcomes were assessed.
Results: Fifty-one patients met the criteria for our study. All patients had treatment to gross disease with margin (CTV1), and all but 1 had treatment to the bilateral necks. The most common treatment schedule (39 patients) was a once-daily fractionation of prescribed doses of 63-66 Gy to the CTV1 and 54 Gy to subclinical sites, delivered in 30 fractions. Twenty-one patients (40%) had gastrostomy tubes placed during therapy; in 4 patients, the tube remained in place for more than 6 months after completion of IMRT. The median follow-up was 45 months. The 2-year actuarial locoregional control, recurrence-free, and overall survival rates were 94%, 88%, and 94%, respectively.
Conclusions: These preliminary data suggest that treatment with IMRT results in favorable locoregional control of small primary oropharynx tumors. IMRT did not appear to have a more favorable acute toxicity profile in this group with respect to the use of a feeding tube; however, the mean dose of radiation delivered to the parotid gland by IMRT was decreased, because 95% of patients had a mean dose of <30 Gy to at least one gland.
Figures
Comment in
-
In regards to Dr. Garden et al. (Int J Radiat Oncol Biol Phys 2007;67:438-444).Int J Radiat Oncol Biol Phys. 2007 May 1;68(1):313-4. doi: 10.1016/j.ijrobp.2007.01.020. Int J Radiat Oncol Biol Phys. 2007. PMID: 17448885 No abstract available.
References
-
- Hunt MA, Zelefsky MJ, Wolden S, et al. Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer. International Journal of Radiation Oncology, Biology and Physics. 2001;49:623–632. - PubMed
-
- Xia P, Fu KK, Wong GW, et al. Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma. International Journal of Radiation Oncology, Biology and Physics. 2000;48:329–337. - PubMed
-
- Eisbruch A, Ship JA, Dawson LA, et al. Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer. World Journal of Surgery. 2003;27:832–837. - PubMed
-
- Butler EB, Teh BS, Grant WHr, et al. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy. International Journal of Radiation Oncology, Biology and Physics. 1999;45:21–32. - PubMed
-
- Chao KS, Ozyigit G, Blanco AI, et al. Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume. International Journal of Radiation Oncology, Biology and Physics. 2004;59:43–50. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
